[Advances in the treatment of endotoxic shock].
Authors present their adopted measures, in the different clinical stages of endotoxic shock with a phisiological approach, paying special attention to those secondary to meningococcal infections.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002317:Cardiovascular Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005440:Fluid Therapy; D006801:Humans; D007362:Intensive Care Units; D008589:Meningococcal Infections / Q000150:complications; D012772:Shock, Septic / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D014812:Vitamin K / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D002317:Cardiovascular Agents; D014812:Vitamin K
Avances en el tratamiento del "shock" endotóxico.